What are the recommended treatments for uncomplicated and complicated urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Urinary Tract Infections (UTIs)

For uncomplicated and complicated UTIs, first-line treatments include fosfomycin trometamol, nitrofurantoin, and pivmecillinam for uncomplicated cases, while fluoroquinolones, cephalosporins, and aminoglycosides are recommended for complicated infections, with treatment choices guided by local resistance patterns. 1, 2

Uncomplicated UTIs in Women

First-line Treatment Options

  • Fosfomycin trometamol 3g as a single dose is highly effective with minimal resistance and low potential for collateral damage 1, 2
  • Nitrofurantoin 100mg twice daily for 5 days (or macrocrystals 50-100mg four times daily) is recommended due to sustained effectiveness and low resistance rates 1, 2
  • Pivmecillinam 400mg three times daily for 3-5 days is appropriate where available (primarily in European countries) 1, 2

Alternative Treatment Options

  • Trimethoprim-sulfamethoxazole 160/800mg twice daily for 3 days if local resistance rates are <20% (not recommended in last trimester of pregnancy) 1, 3
  • Trimethoprim 200mg twice daily for 5 days (avoid in first trimester of pregnancy) 1
  • Cephalosporins (e.g., cefadroxil 500mg twice daily for 3 days) if local E. coli resistance is <20% 1, 2
  • Fluoroquinolones (e.g., ciprofloxacin, levofloxacin) are effective but should be reserved for more serious infections due to their propensity for collateral damage 1, 4

Treatment Duration

  • Single dose: Fosfomycin trometamol 1
  • 3-day regimens: Trimethoprim-sulfamethoxazole, some cephalosporins 1
  • 5-day regimens: Nitrofurantoin, trimethoprim, pivmecillinam 1, 2

Uncomplicated UTIs in Men

  • Trimethoprim-sulfamethoxazole 160/800mg twice daily for 7 days is the primary treatment 1, 2
  • Fluoroquinolones can be prescribed according to local susceptibility patterns 1, 2
  • Longer treatment duration (7 days) is typically recommended for men 1, 3

Complicated UTIs and Pyelonephritis

Outpatient Treatment

  • Oral ciprofloxacin 500mg twice daily for 7 days is appropriate when fluoroquinolone resistance is <10% 1
  • Extended-release ciprofloxacin 1000mg daily for 7 days or levofloxacin 750mg daily for 5 days are effective options 1
  • Consider an initial IV dose of ceftriaxone 1g or a 24-hour dose of an aminoglycoside if fluoroquinolone resistance exceeds 10% 1
  • Trimethoprim-sulfamethoxazole 160/800mg twice daily for 14 days if the pathogen is known to be susceptible 1

Inpatient Treatment

  • Initial IV therapy with one of the following 1:
    • Fluoroquinolone (if local resistance <10%)
    • Aminoglycoside with or without ampicillin
    • Extended-spectrum cephalosporin or penicillin (with or without aminoglycoside)
    • Carbapenem
  • Treatment should be tailored based on culture and susceptibility results 1

Special Considerations

Recurrent UTIs

  • Always obtain a urine culture for diagnosis 1, 2
  • For women whose symptoms don't resolve by the end of treatment or recur within 2 weeks, perform urine culture and susceptibility testing 1
  • Retreatment with a 7-day regimen using a different agent is recommended for recurrence 1

Antimicrobial Resistance Concerns

  • Local resistance patterns should guide empiric therapy choices 1
  • Escherichia coli is the predominant pathogen (75-95%) in uncomplicated UTIs 1
  • Amoxicillin or ampicillin should not be used for empirical treatment due to poor efficacy and high worldwide resistance 1
  • β-lactams (except pivmecillinam) generally have inferior efficacy and more adverse effects compared to other UTI antimicrobials 1, 5

Diagnostic Approach

  • Diagnosis of uncomplicated cystitis can be made with high probability based on symptoms (dysuria, frequency, urgency) and absence of vaginal discharge 1
  • Urine culture is recommended for suspected pyelonephritis, symptoms that don't resolve or recur within 4 weeks after treatment, women with atypical symptoms, and pregnant women 1
  • For typical uncomplicated cystitis, urine analysis provides minimal increase in diagnostic accuracy 1

Treatment Algorithm

  1. Assess if uncomplicated or complicated UTI:

    • Uncomplicated: Healthy non-pregnant women with no urological abnormalities
    • Complicated: Men, pregnant women, urological abnormalities, immunocompromise, or systemic symptoms
  2. For uncomplicated UTI in women:

    • First choice: Fosfomycin 3g single dose, nitrofurantoin 100mg BID for 5 days, or pivmecillinam 400mg TID for 3-5 days 1, 2
    • Second choice: Trimethoprim-sulfamethoxazole 160/800mg BID for 3 days (if local resistance <20%) 1
  3. For uncomplicated UTI in men:

    • Trimethoprim-sulfamethoxazole 160/800mg BID for 7 days 1, 2
    • Fluoroquinolones based on local susceptibility 1, 2
  4. For complicated UTI/pyelonephritis:

    • Outpatient: Ciprofloxacin 500mg BID for 7 days or levofloxacin 750mg daily for 5 days 1
    • Consider initial IV dose of ceftriaxone 1g if fluoroquinolone resistance >10% 1
    • Inpatient: IV therapy based on local resistance patterns 1
  5. For recurrent UTI:

    • Always obtain urine culture 1, 2
    • Use different agent than previous treatment for 7 days 1
    • Consider prophylactic strategies for frequent recurrences 2, 3

Common Pitfalls and Caveats

  • Fluoroquinolones should be reserved for more serious infections due to risk of collateral damage and increasing resistance 1, 5
  • β-lactams (except pivmecillinam) should be used with caution due to inferior efficacy 1
  • Routine post-treatment urinalysis or cultures are not indicated for asymptomatic patients 1
  • Local resistance patterns significantly impact treatment success - what works in one region may not work in another 1, 6
  • In elderly patients, genitourinary symptoms are not necessarily related to cystitis 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tratamiento de Infecciones Urinarias

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.